About: 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2004 (uk) im Oktober 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2004 (ast) scientific article published on 01 October 2004 (en)
publication date	wds:Q58235911-205163E0-C0AA-4DC4-BC2C-7B2F4359EB43
publication date	2004-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58235911-2D46A8AD-CC23-4A7E-9E62-B58D200908D9
language of work or name	English
author name string	wds:Q58235911-0E672310-6CC1-4C12-8D76-C1F6EBBD8048 wds:Q58235911-2F9A13B1-B73E-4197-8354-F72231A16D8B wds:Q58235911-9E52737E-0DE0-4700-B2A6-EA2CAE46C1E9 wds:Q58235911-B6504363-059E-4080-8772-38AA35EC2B54
author name string	Man-Fung Yuen Danny Ka-Ho Wong Annie On-On Chan Wei-Ling Lim
rdfs:label	18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (en) 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (nl)
skos:prefLabel	18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (en) 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (nl)
name	18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (en) 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (nl)
author	wds:Q58235911-85B869C3-E7D5-4EC5-B39D-3B3894FEC31B wds:Q58235911-8655308A-3B7F-437F-A8E1-EDA732EE6796
author	Ching-Lung Lai Siu-Man Sum
title	wds:Q58235911-92C98299-6059-4D94-8649-C5FEA04D8D71
title	18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children (en)
page(s)	wds:Q58235911-C4767517-CB35-437B-B4E4-452300BC9FD0
page(s)	941-945
instance of	wds:Q58235911-7FFFB429-2720-4417-BA83-49AC87A557F4
instance of	scholarly article
uses	wds:Q58235911-37F7541C-1F9D-4DEB-A07C-AB83AEE54FC3
uses	randomized experiment
main subject	wds:Q58235911-07DAD04B-E359-4420-965B-12DF09554072 wds:Q58235911-AB68FD24-818D-4C4B-BCAA-4A4021D9461D
main subject	randomized experiment hepatitis B
PubMed ID	wds:Q58235911-397DD9B4-A95F-4FA2-A9FD-6A432808FADE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15476159
PubMed ID	15476159
published in	wds:Q58235911-2A4E42AD-08F0-45CA-A9A9-1A23630C0612
published in	Clinical Gastroenterology and Hepatology
issue	wds:Q58235911-C7C7C06F-1E0F-4680-8C5B-B7DAB3C2118B
volume	wds:Q58235911-18A2D8F4-EE3E-4609-BA7A-CCEFF7226B3F
issue	10
volume	2
DOI	wds:Q58235911-D52DB516-000D-4978-A945-419CB7AC4442
DOI	http://dx.doi.org/10.1016/S1542-3565(04)00384-2
DOI	10.1016/S1542-3565(04)00384-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58235911
is cites work of	Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status Hepatitis B vaccination: to boost or not to boost? Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review Hepatitis B immunization strategies: timing is everything Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination Booster dose vaccination for preventing hepatitis B Booster dose vaccination for preventing hepatitis B Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report Long-term efficacy of the hepatitis B vaccine in a high-risk group Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves Three decades of hepatitis B control with vaccination Hepatitis B and the need for a booster dose Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination The worldwide impact of vaccination on the control and protection of viral hepatitis B Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran Hepatitis B and C infection in international travelers Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges. Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay The necessity of booster vaccination after neonatal hepatitis B vaccination. Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China. A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea. Twenty years of universal vaccination against hepatitis B in Italy: achievements and challenges The efficacy of hepatitis B vaccination program in upper Egypt: Flow cytometry and the evaluation of long term immunogenicity. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada Booster dose vaccination for preventing hepatitis B
is cites work of	wds:Q26471510-30ED37E6-909E-4F8F-80C8-C17574EFB5CA wds:Q51035575-DD3A6E29-84C5-44B3-BAA1-6E64105268CE wds:Q57922923-BC8C815D-4F3F-491A-B5B1-B556BF3E406B wds:Q83078584-06A3D704-C2E8-46A7-9E07-2539393601DF wds:Q24236587-3AE49395-2FDA-4D3A-B482-5DDA2AC81C0E wds:Q37540487-ABD8F751-065F-4419-BBA3-270E088663F3 wds:Q37084602-32F1BAD7-FF08-4C20-A544-98F530D3FE1B wds:Q44164538-8B06F2C4-4A9B-495D-9DC4-2FD707FE8B22 wds:Q45364396-B3306961-9BA2-4382-A3F8-ACFAF0E14332 wds:Q52651632-56DC4FD7-9F32-4257-A73B-876AFBA3FCE4 wds:Q38111651-6C2CDD7A-34C3-43C8-A5DE-8103EBA0E3C3 wds:Q38098235-451E2D55-5A92-4146-9AE5-59C137CD6A05 wds:Q39206649-EFAAA602-4635-43FA-BC34-11F7EB54E5C4 wds:Q44263917-B0D23C65-83DA-4F95-9839-42AB7BB9667D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software